Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Telatinib |
Trade Name | |
Synonyms | BAY 57-9352 |
Drug Descriptions |
Telatinib (BAY 57-9352) inhibits VEGFR2, VEGFR3, PDGFR-beta (PDGFRB), and KIT, which may result in decreased proliferation and angiogenesis in tumors expressing these factors (PMID: 29511030). |
DrugClasses | KIT Inhibitor 57 PDGFR-beta Inhibitor 14 VEGFR2 Inhibitor 37 VEGFR3 Inhibitor 6 |
CAS Registry Number | 332012-40-5 |
NCIT ID | C87837 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + Telatinib | Bevacizumab Telatinib | 0 | 0 |
Pembrolizumab + Telatinib | Pembrolizumab Telatinib | 0 | 1 |
Telatinib | Telatinib | 0 | 0 |